Latest news

ClinicalJuly 1, 2026

Corxel Ready to Make Waves Worldwide After Positive Oral GLP-1 Phase 2 Results

Less than six months after securing hundreds of millions of dollars in financing to advance its oral GLP-1 program,...

InsightsJuly 1, 2026

Top 10 Real-World Use Cases for AI in Clinical Development

Executive Summary Artificial intelligence is rapidly becoming one of the most influential technologies in clinical development. Pharmaceutical companies, biotechnology firms,...

InsightsJuly 1, 2026

Why Medical Affairs Teams Need New Skills for the Next Decade

Executive Summary Medical affairs has become one of the fastest-evolving functions in the pharmaceutical industry. Traditionally, medical affairs organizations focused on...

RegulatoryJuly 1, 2026

Viridian Therapeutics’ Lumvoa Gets FDA Nod For Thyroid Eye Disease Treatment

Viridian Therapeutics announced that the U.S. Food and Drug Administration (FDA) has approved Lumvoa for the treatment of thyroid...

ClinicalJuly 1, 2026

AstraZeneca Presents Phase 3 Efzimfotase Alfa Data in Pediatric Hypophosphatasia Studies

AstraZeneca has released detailed results from two phase 3...

ManufacturingJuly 1, 2026

fda selects seven drugmakers for precheck pilot to accelerate u.s. manufacturing reviews

The U.S. Food and Drug Administration (FDA) has selected...

ClinicalJuly 1, 2026

AbbVie and Genmab Report Positive Phase 3 Results for Epkinly Combination in Diffuse Large B-Cell Lymphoma

AbbVie and Genmab have reported positive topline results from a Phase 3 clinical trial evaluating Epkinly (epcoritamab) in combination...

ClinicalJuly 1, 2026

Vistagen Misses Second Phase 3 Social Anxiety Trial but Sees Potential Path Forward

Vistagen has reported another setback for its lead anxiety treatment fasedienol, after the investigational nasal spray failed to meet...

InsightsJune 29, 2026

Top 10 Trends Reshaping Biotech R&D Infrastructure

Executive Summary Biotechnology research and development is undergoing one of the most significant infrastructure transformations in its history. For decades, biotech...

InsightsJune 29, 2026

The Rise of Multi-Omics in Drug Development

Executive Summary The pharmaceutical industry has always depended on a...

ClinicalJune 29, 2026

Ollin Brings in $330M to Advance Eye Disease Drug Through Phase 3 Trial

Six months after reporting early clinical data that outperformed...

CommercialJune 29, 2026

BIO 2026: A Saudi sovereign wealth fund business and Flagship sign a research partnership

Flagship and Lean are looking to combine Lean's platform and ecosystem with Flagship's expertise in building and launching biopharmaceutical...

ManufacturingJune 29, 2026

ADC Therapeutics Announces Workforce Reduction as It Advances Zynlonta Regulatory Plans

ADC Therapeutics has announced a new restructuring plan that includes workforce reductions and cost-saving measures as the company concentrates...

InsightsJune 29, 2026

The Coming Talent Crisis in Life Sciences

Executive Summary The life sciences industry is entering one of the most significant workforce transitions in its history. For decades, pharmaceutical,...